The global dialysis device and concentrates market is poised for substantial growth, with forecasts indicating a surge from USD 21,663.5 million in 2023 to USD 34,824.85 million by 2033, reflecting a robust Compound Annual Growth Rate (CAGR) of 4.9%. This significant expansion underscores the escalating demand for dialysis solutions worldwide.
Key market players are strategically aligning themselves through agreements and partnerships with regional and domestic counterparts to fortify their market presence and cater to a wider customer base. These alliances not only enhance market penetration but also foster innovation and technological advancements to meet evolving consumer needs.
Get More Insights Dialysis Device and Concentrates Market Sample Report Copy
Technological innovations are driving growth opportunities, particularly in emerging economies, where the establishment of dialysis clinics, home dialysis options, and government support for End-Stage Renal Disease (ESRD) are fueling market expansion. The advent of advanced hemodialysis procedures and the development of sophisticated devices further propel demand for dialysis concentrates, particularly in regions witnessing a surge in renal failure cases attributed to conditions such as hypertension and diabetes.
“The rise in demand for dialysis treatments, coupled with the scarcity of organ donations, serves as a catalyst for market growth,” said FMI. “As the global healthcare landscape evolves, we remain committed to driving innovation and forging strategic partnerships to address the pressing needs of patients worldwide.”
With an increasing number of patients grappling with kidney diseases, the imperative for effective dialysis solutions has never been more pronounced. The global dialysis device and concentrates market are poised to witness unprecedented growth, driven by a confluence of factors ranging from technological advancements to strategic collaborations and rising healthcare demands.
Key Takeaways:
- By 2033, the dialysis device and concentrate market in the United Kingdom is likely to expand, with a CAGR of 4.3%.
- In 2022, the United States developed the dialysis device and focused business with a share of 33.8%.
- The dialysis device and concentrates market grew considerably to USD 20,858 million in 2022.
- The dialysis device and concentrates market expanded with a CAGR of 3.1% between 2018 to 2022.
- By 2033, China’s dialysis device and concentrate market are projected to develop with a CAGR of 6.5%.
- By 2033, India’s dialysis device and concentrates industry is projected to expand with a CAGR of 3.1%.
- Japan’s dialysis device and concentrates industry grew significantly, with a 1.6% share in 2022.
- Australia’s dialysis device and concentrate market is likely to expand with a CAGR of 1.0% by 2033.
- Germany’s dialysis device and concentrates business grew, with a share of 7.5% in 2022
- In 2022, based on product, hemodialysis machines dominated the market, with a share of 34.2%.
- In 2022, the hospitals’ segment led the market, with a share of 37.6%, based on end users.
A Full Report Overview Dialysis Device and Concentrates Market
Key Players’ Strategies and Recent Developments:
- Medtronic introduced a dialysis device for newborn and pediatric care in the United States in December 2020. Additionally, in January 2021, the United States Food and Drug Administration granted 510(k) clearance to Quanta Dialysis Technologies Ltd, a British medical technology leader developing cutting-edge dialysis products and services, allowing it to market its compact, easy-to-use SC+ hemodialysis system.
- Rockwell Medical, Inc. stated in April 2022 that it had expanded its cooperation with DaVita Inc. and is revising some aspects of its supply contracts with clients to stabilize its concentrated business.
- The SURDIAL DX Hemodialysis System was introduced in the US in March 2022 by Nipro Medical Company, a producer and seller of renal, vascular, and medical-surgical devices.
- Baxter International Inc.
- B. Braun Melsungen AG
- Fresenius SE & Co. KGaA
- DaVita Healthcare Partners, Inc.
- Nipro Corporation
- Asahi Kasei Medical Co. Ltd.
- Mar Cor Purification, Inc.
- Nikkiso Co Ltd.
- NxStage Medical, Inc.
- Rockwell Medical
- Farmasol
- Browndove Healthcare
Key segments:
By Product Type:
- Hemodialysis Machine
- A.V. Fistula Needle
- A.V. Access Graft
- Dialysis Catheter
- Dialysis Concentrates
- Dialyzer
- Dialyzer Reprocessing Machine
- Hemodialysis Bloodline and Tubing Set
- Declotting Device
- Water Treatment System
- introducer Sheath and Guidewire
By End-User:
- In-center Dialysis
- Hospitals
- Independent Dialysis Centres
- Home Dialysis
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube